Breaking News Instant updates and real-time market news.

BLUE

bluebird bio

$65.24

-0.31 (-0.47%)

07:54
10/14/16
10/14
07:54
10/14/16
07:54

bluebird bio outlook has improved, says SunTrust

SunTrust analyst Edward Nash believes that the improvement in the transduction efficiency of bluebird's LentiGlobin should enable the company "to target the entire transfusion-dependent B-thalassemia population" for the first time. Nash adds that the changes should also improve LentiGlobin's efficacy in sickle cell. He reiterates a $115 price target and Buy rating on the stock.

  • 06

    Nov

  • 29

    Nov

BLUE bluebird bio
$65.24

-0.31 (-0.47%)

10/07/16
GSCO
10/07/16
NO CHANGE
GSCO
Smid-cap Biotech sector upgraded to Attractive from Neutral at Goldman
Goldman analyst Salveen Richter upgraded the Smid-cap biotechnology to Attractive and said he favors and companies with near-term pipeline data or regulatory events where he has conviction.Names he recommends are Buy rated BioMarin (BMRN), bluebird bio (BLUE), GW Pharma (GWPH), Incyte (INCY), Kite (KITE), and Sage (SAGE).
10/14/16
CANT
10/14/16
DOWNGRADE
CANT
Sell
bluebird bio downgraded to Sell from Hold at Cantor
Cantor Fitzgerald analyst Elemer Piros downgraded bluebird bio to Sell and cut his price target for the shares to $37 from $42.
10/14/16
CANT
10/14/16
DOWNGRADE
Target $37
CANT
Sell
Cantor cuts bluebird bio to Sell with $37 price target
Cantor Fitzgerald analyst Elemer Piros downgraded bluebird bio to Sell from Hold and dropped his price target for the shares to $37 from $42. The biotech focused on developing gene therapies closed yesterday down 31c to $64.24. The analyst sees a lack of catalysts as he does not expect data to be announced at this year's American Society of Hematology conference to de-risk the hemoglobinopathy programs. Bluebird disclosed yesterday that all future LentiGlobin trials going forward will use its improved manufacturing process, and those trials are just beginning, Piros tells investors in a research note. As such, initial data on improved transduction efficiency may not become available until 2018, the analyst contends. With this year's ASH meeting not a catalyst, Piros expects selling pressure on bluebird shares.
10/14/16
LEER
10/14/16
NO CHANGE
Target $80
LEER
Outperform
bluebird bio price target raised to $80 from $67 at Leerink
Leerink analyst Michael Schmidt raised his price target for bluebird bio to $80 from $67 as he sees the clinical development and regulatory path for the company's pipeline products incrementally more de-risked. While development of key product LentiGlobin in transfusion-dependent beta-thalassemia and severe sickle cell disease has been more complex than initially anticipated, the analyst believes bluebird bio is well positioned to overcome remaining technical hurdles. He reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

EFX

Equifax

$98.25

2.25 (2.34%)

07:41
09/22/17
09/22
07:41
09/22/17
07:41
Technical Analysis
Technical View: Equifax trades higher, analyst action »

Shares are back well…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AA

Alcoa

$46.25

-1.25 (-2.63%)

07:41
09/22/17
09/22
07:41
09/22/17
07:41
Downgrade
Alcoa rating change  »

Alcoa downgraded to Hold,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$68.84

0.17 (0.25%)

07:40
09/22/17
09/22
07:40
09/22/17
07:40
Earnings
CarMax reports Q2 EPS 98c, consensus 95c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

SYK

Stryker

$140.67

-2.04 (-1.43%)

, ZBH

Zimmer Biomet

$113.06

-2.92 (-2.52%)

07:40
09/22/17
09/22
07:40
09/22/17
07:40
Recommendations
Stryker, Zimmer Biomet analyst commentary  »

Growth investors should…

SYK

Stryker

$140.67

-2.04 (-1.43%)

ZBH

Zimmer Biomet

$113.06

-2.92 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SAVE

Spirit Airlines

$34.01

1.31 (4.01%)

07:39
09/22/17
09/22
07:39
09/22/17
07:39
Conference/Events
Spirit Airlines to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

IBM

IBM

$145.26

-0.62 (-0.43%)

, WBA

Walgreens Boots Alliance

$78.20

-0.64 (-0.81%)

07:39
09/22/17
09/22
07:39
09/22/17
07:39
Hot Stocks
IBM announces new agreement with Walgreens to deploy IBM retail analytics »

IBM (IBM) announced a new…

IBM

IBM

$145.26

-0.62 (-0.43%)

WBA

Walgreens Boots Alliance

$78.20

-0.64 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 23

    Sep

  • 22

    Oct

  • 25

    Oct

  • 15

    Nov

07:38
09/22/17
09/22
07:38
09/22/17
07:38
Conference/Events
Federal Reserve Bank of Dallas President participates in a conference »

Dallas Federal Reserve…

07:37
09/22/17
09/22
07:37
09/22/17
07:37
Conference/Events
Federal Reserve Bank of Kansas City President to speak at conference »

Kansas City Federal…

MYGN

Myriad Genetics

$33.61

0.1 (0.30%)

07:36
09/22/17
09/22
07:36
09/22/17
07:36
Recommendations
Myriad Genetics analyst commentary  »

Myriad Genetics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

VSAR

Versartis

$21.60

-0.25 (-1.14%)

07:35
09/22/17
09/22
07:35
09/22/17
07:35
Downgrade
Versartis rating change  »

Versartis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$13.41

-0.33 (-2.40%)

, MSFT

Microsoft

$74.21

-0.73 (-0.97%)

07:35
09/22/17
09/22
07:35
09/22/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

AMD

AMD

$13.41

-0.33 (-2.40%)

MSFT

Microsoft

$74.21

-0.73 (-0.97%)

INTC

Intel

$37.20

0.13 (0.35%)

ABBV

AbbVie

KMI

Kinder Morgan

$19.32

-0.45 (-2.28%)

GLNG

Golar LNG

$21.34

0.19 (0.90%)

HAS

Hasbro

$94.84

-0.68 (-0.71%)

MIK

Michaels

$21.38

-0.04 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

  • 05

    Oct

  • 22

    Oct

  • 23

    Oct

  • 08

    Nov

VSAR

Versartis

$21.60

-0.25 (-1.14%)

07:34
09/22/17
09/22
07:34
09/22/17
07:34
Downgrade
Versartis rating change  »

Versartis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGRX

Agile Therapeutics

$3.77

0.04 (1.07%)

07:34
09/22/17
09/22
07:34
09/22/17
07:34
Initiation
Agile Therapeutics initiated  »

Agile Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Dec

SECO

Seeco Holding

07:33
09/22/17
09/22
07:33
09/22/17
07:33
Syndicate
Seeco Holding 8.5M share IPO priced at $13.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

AAXN

Axon

$22.80

-0.11 (-0.48%)

07:32
09/22/17
09/22
07:32
09/22/17
07:32
Hot Stocks
Axon receives multiple orders for TASER X26P, TASER X2 smart weapons »

Axon announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$35.91

-0.06 (-0.17%)

07:32
09/22/17
09/22
07:32
09/22/17
07:32
Recommendations
Micron analyst commentary  »

Micron's November…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

FGP

Ferrellgas Partners LP

$5.02

-0.13 (-2.52%)

, MDU

MDU Resources

$26.21

-0.19 (-0.72%)

07:32
09/22/17
09/22
07:32
09/22/17
07:32
Hot Stocks
Ferrellgas Partners LP appoints Doran Schwartz as CFO »

Ferrellgas Partners L.P.…

FGP

Ferrellgas Partners LP

$5.02

-0.13 (-2.52%)

MDU

MDU Resources

$26.21

-0.19 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

FINL

Finish Line

$9.22

-0.21 (-2.23%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Technical Analysis
Technical View: Finish Line drops after earnings and outlook »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

PANW

Palo Alto Networks

$140.06

-1.69 (-1.19%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Conference/Events
Palo Alto Networks to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 07

    Dec

  • 11

    Dec

QCOM

Qualcomm

$52.03

0.05 (0.10%)

, NXPI

NXP Semiconductors

$112.72

0.17 (0.15%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Hot Stocks
Qualcomm extends cash tender offer for shares of NXP Semiconductors »

Qualcomm (QCOM) announced…

QCOM

Qualcomm

$52.03

0.05 (0.10%)

NXPI

NXP Semiconductors

$112.72

0.17 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

, TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Hot Stocks
Breaking Hot Stocks news story on Sprint, T-Mobile »

Sprint up 2.6% after…

S

Sprint

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

AZN

AstraZeneca

$32.81

-0.12 (-0.36%)

07:31
09/22/17
09/22
07:31
09/22/17
07:31
Upgrade
AstraZeneca rating change  »

AstraZeneca upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 08

    Nov

SXT

Sensient

$75.90

0.19 (0.25%)

07:30
09/22/17
09/22
07:30
09/22/17
07:30
Initiation
Sensient initiated  »

Sensient initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

, CAR

Avis Budget

$38.08

0.16 (0.42%)

07:30
09/22/17
09/22
07:30
09/22/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

MRVL

Marvell

CAR

Avis Budget

$38.08

0.16 (0.42%)

GIS

General Mills

$51.69

-0.48 (-0.92%)

FINL

Finish Line

$9.22

-0.21 (-2.23%)

HOG

Harley-Davidson

$47.96

-0.39 (-0.81%)

JBLU

JetBlue

$18.90

-0.35 (-1.82%)

MXWL

Maxwell

$4.97

-0.155 (-3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 02

    Oct

  • 05

    Oct

  • 17

    Oct

  • 08

    Nov

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

, S

Sprint

07:29
09/22/17
09/22
07:29
09/22/17
07:29
Periodicals
T-Mobile, Sprint close to agreeing on deal terms, Reuters reports »

T-Mobile (TMUS) and…

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

S

Sprint

DTEGY

Deutsche Telekom

$18.36

-0.39 (-2.08%)

SFTBF

SoftBank

$81.50

-1.14 (-1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.